VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price was down 14.7% during trading on Wednesday . The company traded as low as C$0.15 and last traded at C$0.15. Approximately 266,015 shares were traded during trading, a decline of 10% from the average daily volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Price Performance
The business has a 50-day moving average price of C$0.10 and a 200 day moving average price of C$0.13. The company has a market cap of C$23.52 million, a price-to-earnings ratio of -4.48 and a beta of 0.39. The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Do ETFs Pay Dividends? What You Need to Know
- Rockwell Automation Poised to Gain From U.S. Tariffs & Onshoring
- Investing in the High PE Growth Stocks
- 3 Companies Buying Back Stock—Why It Matters
- Top Stocks Investing in 5G Technology
- Institutions Bought 3 Stocks Heavily in Q1 2025
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
